严重股骨干骨折患者中损伤控制骨科与早期全面治疗相比不提供生存优势并增加严重并发症风险
该研究基于创伤质量改进项目数据库(2007–2021年),纳入14岁以上、损伤严重度评分>15的股骨干骨折患者44,577例,比较损伤控制骨科(DCO)与早期全面治疗(ETC)的结局。经逆概率治疗加权后行二项逻辑回归分析,DCO组死亡率无生存优势(OR 0.92),但与急性呼吸窘迫综合征(OR 1.64)、急性肾损伤(OR 1.57)、严重脓毒症(OR 1.64)和深静脉血栓(OR 1.64)风险升高相关。按骨折类型(开放或闭合)分层后,DCO与死亡率降低仍无关联。作者认为,生理代偿良好的患者可更多采用ETC,与骨折类型无关。
要点
- DCO与ETC相比无生存优势:死亡率OR 0.92(DCO组死亡率2.1%)。
- DCO与急性呼吸窘迫综合征风险升高相关(OR 1.64)。
- DCO与急性肾损伤风险升高相关(OR 1.57)。
- DCO与严重脓毒症(OR 1.64)和深静脉血栓(OR 1.64)风险升高相关。
- 按骨折类型(开放或闭合)分层后,DCO与死亡率降低仍无关联。
适用人群与场景
- 成人患者,年龄14岁或以上,股骨干骨折,损伤严重度评分>15,数据来自创伤质量改进项目数据库2007–2021年。
- 按骨折类型分为开放或闭合骨折进行分层分析。
诊断标准与关键阈值
- 纳入标准:年龄≥14岁,股骨干骨折,损伤严重度评分>15。
研究设计与关键结果
- 研究类型:基于创伤质量改进项目数据库(2007–2021年)的分析;共纳入44,577例股骨干骨折患者。
- 主要结局:急性呼吸窘迫综合征、急性肾损伤、严重脓毒症、深静脉血栓和死亡率。
- DCO组死亡率2.1%;DCO与ETC相比无生存优势(OR 0.92)。
- DCO与急性呼吸窘迫综合征风险升高相关(OR 1.64)。
- DCO与急性肾损伤风险升高相关(OR 1.57)。
- DCO与严重脓毒症风险升高相关(OR 1.64)。
- DCO与深静脉血栓风险升高相关(OR 1.64)。
- 按骨折类型(开放或闭合)分层后,DCO与死亡率降低仍无关联。
证据类型、等级与局限
- 证据类型:治疗/护理管理研究,证据等级Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,生理代偿良好的患者可更多采用早期全面治疗(ETC),与骨折类型无关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Damage control orthopedics (DCO) was proposed to minimize the second hit of extensive surgical procedures in severely injured patients when treated with early fracture fixation (early total care [ETC]). The impact of DCO and ETC on the outcomes of severely injured patients sustaining femoral shaft fractures (FSFs) is unclear. We hypothesized that DCO is associated with lower mortality and decreased incidence of complications compared with ETC.
METHODS: The Trauma Quality Improvement Project database was queried from 2007 to 2021. Adult patients 14 years or older with FSF and Injury Severity Score of >15 were included. Patients were divided into ETC and DCO groups and stratified according to fracture type: open or closed. The primary outcomes included acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), severe sepsis, deep venous thrombosis (DVT), and mortality. Inverse probability treatment of weighting was used to balance the two cohorts of interest. A binomial logistic regression analysis was performed after inverse probability treatment of weighting to identify potential associations between the type of fixation procedure and the outcomes of interest.
RESULTS: A total of 44,577 FSF patients were included. Mortality was 2.1%. No survival advantage was observed in the DCO group (odds ratio [OR], 0.92). However, significant associations between DCO and the risk of ARDS (OR, 1.64), AKI (OR, 1.57), severe sepsis (OR, 1.64), and DVT (OR, 1.64) were identified. Damage control orthopedics was not associated with decreased mortality after stratifying patients according to the fracture type and the type of operation.
CONCLUSION: Damage control orthopedics is not associated with improved survival of severely injured patients with FSF. Damage control orthopedics is associated with an increased risk of ARDS, AKI, severe sepsis, and DVT compared with ETC. These findings persisted after analyzing the type of fracture. These results are significant for clinical practice, as more patients could be treated by ETC when compensated physiologically, independent of the fracture type.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Coimbra BC, Kwon J, Zakhary B, et al. Damage control does not offer a survival advantage and increases the risk of serious complications compared with early total care in severely injured patients with femoral shaft fractures. J Trauma Acute Care Surg. 2025. PMID: 40107976. doi:10.1097/TA.0000000000004594
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。